Jardiance 25mg is a prescription tablet containing Empagliflozin 25mg. It belongs to the SGLT2 inhibitor class of medicines.
Empagliflozin works mainly through the kidneys by reducing glucose reabsorption. As a result, more glucose is passed out of the body through urine, helping lower blood glucose levels.
Jardiance is used for appropriate patients with Type 2 Diabetes and is also used for certain cardiovascular and chronic kidney disease indications.
When prescribed appropriately, Jardiance may:
Jardiance is not insulin and is not intended as a general weight-loss medicine.
Jardiance blocks a protein called SGLT2 in the kidneys.
Normally, the kidneys reabsorb glucose back into the bloodstream. Empagliflozin reduces this reabsorption, allowing more glucose to leave the body in urine.
This helps reduce blood glucose levels.
Jardiance may be prescribed to appropriate:
The correct dose depends on the patient's condition, kidney function and other medicines.
Take Jardiance exactly as prescribed by your doctor.
For blood-glucose control in Type 2 Diabetes, the usual starting dose is generally 10mg once daily. A doctor may increase it to 25mg once daily when additional glycemic control is required and the patient can tolerate it.
Jardiance can generally be taken with or without food.
Take it at approximately the same time each day.
Do not increase the dose from 10mg to 25mg yourself.
Adequate fluid intake is important unless your doctor has instructed you to restrict fluids.
Jardiance is a prescription medicine and should be used under medical supervision.
Tell your doctor if you have:
Jardiance can increase urination and may cause dehydration or low blood pressure.
It can also increase the risk of genital fungal infections and urinary tract infections.
A rare but serious complication is diabetic ketoacidosis (DKA). Seek urgent medical attention if you experience severe nausea, vomiting, abdominal pain, unusual weakness, difficulty breathing or confusion.
Jardiance 25mg contains Empagliflozin and is used for appropriate patients with Type 2 Diabetes. It also has cardiovascular and kidney-related indications for certain patients.
No. Jardiance is an SGLT2 inhibitor; it is not insulin.
Yes. It increases the amount of glucose eliminated through urine, helping lower blood glucose.
Yes. Empagliflozin is used to improve glycemic control in appropriate adults with Type 2 Diabetes.
Usually, 10mg once daily is the starting dose for glycemic control, with 25mg used when additional control is needed and appropriate. Do not start with 25mg without medical advice.
Yes. It can generally be taken with or without food.
It can. Because the medicine increases glucose excretion through urine, increased urination may occur.
Yes. Increased urination can contribute to dehydration and low blood pressure, particularly in susceptible people.
No. Jardiance is primarily a prescription medicine for its approved diabetes, cardiovascular and kidney-related indications. It should not be self-used specifically for weight loss.
Yes, doctors may prescribe it together with other diabetes medicines when appropriate. Some combinations can increase the risk of low blood sugar.
Possible side effects include increased urination, dehydration, urinary tract infections and genital fungal infections.
A current Pakistani market listing shows approximately Rs. 8,000 for a 30-tablet pack. Actual prices can change.
Jardiance is a Boehringer Ingelheim product. The manufacturing facility can differ according to market and product batch.
No. Do not stop or change your diabetes medicine without consulting your doctor.
Suitability depends on kidney function, medical history, diabetes type, current medicines and other factors. A doctor should determine whether Jardiance is appropriate for you.
Customers Reviews For Jardiance 25mg (Empagliflozin) Tablets Price in Pakistan